FBLG
FBLG
NASDAQ · Biotechnology

Fibrobiologics Inc

$0.97
-0.03 (-2.81%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,991.3% upside
Low Target $14.74
Average Target $20.24
High Target $23.30
Current Price $0.97
Current
$0.97
Target
$20.24
$14.74 $20.24 avg $23.30
Scenario Analysis
Bear Case
$14.74
1,423.0%
Low target
Base Case
$20.24
+1,991.3%
Avg target
Bull Case
$23.30
+2,307.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$9.60
-89.9% from high
52-Week Low
$0.62
+56.1% from low
Target vs 52W High
$20.24
+110.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%